Overview: Vitamin Screen Panel
Introduction: The Vitamin Screen Panel is a diagnostic tool designed for vitamin deficiency screening using serum samples. In India, combined vitamin D and B12 deficiencies affect a large proportion of the population (vitamin D ~70-90 percent, B12 ~40-70 percent in vegetarians/low-SES groups), contributing to anemia, neuropathy, fatigue, bone pain, and increased infection risk, especially in rural/low-SES, pregnant, and elderly individuals due to poor diet/sun exposure. High morbidity from under-testing leading to delayed supplementation, causing irreversible neurological damage (B12) or osteomalacia/fractures (D). Per nutrition/endocrinology practices aligned with ICMR, National Nutrition Monitoring Bureau, and Indian Dietetic Association guidelines, the test employs immunoassay for vitamin D and vitamin B12 over 1â€"2 days with high accuracy, valuable for baseline nutritional assessment and monitoring replacement. This diagnostic falls under nutritional screening and targets patients with fatigue, anemia, neuropathy, or high-risk groups (vegetarians, pregnancy, elderly), addressing accurate detection to guide cholecalciferol/cobalamin supplementation. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling early dual-vitamin profiling and reducing deficiency-related complications. Its serum-based approach ensures reliable vitamin measurement.
Other Names: Vit Screen Pnl.
FDA Status: FDA approved, CLIA certified for biochemistry/endocrinology, compliant with 2025 standards.
Historical Milestone: Vitamin D + B12 combined screening standard in malnutrition workup; in India, expanding in preventive health programs.
Purpose: The test assesses 2 parameters including vitamin D to guide vitamin deficiency screening, detect low levels, inform supplementation.
Test Parameters: 1. Vitamin D, 2. Vitamin B12.
Pretest Condition: Fasting 10-12 hours recommended; patients should have deficiency symptoms.
Specimen: 3 mL serum in 1 SST, transported within specified times to maintain sample viability.
Sample Stability at Room Temperature: 8 hours with proper handling to preserve vitamin integrity, ensuring reliable test performance.
Sample Stability at Refrigeration: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.
Sample Stability at Frozen: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.
Medical History: Patients should provide details on diet (vegetarianism), fatigue, neuropathy.
Consent: Written informed consent is required, detailing the test's purpose, potential risks of undetected deficiency including anemia/neuropathy, benefits of screening, and minimal discomfort from venipuncture.
Procedural Considerations: The test involves sample processing using immunoassay by trained personnel to ensure sterile technique, avoid hemolysis, and interpret results within 1â€"2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.
Factors Affecting Result Accuracy: Delays beyond stability periods, improper storage conditions, hemolysis can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.
Clinical Significance: Low vitamin D/B12 indicates deficiency, necessitating specialist input.
Specialist Consultation: Endocrinologists or nutritionists should be consulted for management.
Additional Supporting Tests: CBC, PTH, homocysteine for confirmation.
Test Limitations: Dietary/seasonal variation; comprehensive approach required.
References: Indian Journal of Nutrition 2024, Vitamin Studies India 2023.
